[ad_1] Post Holdings’ Rob Vitale, who is on leave as CEO, told analysts he will undergo radiation and chemotherapy treatment for cancer. Post announced on Nov. 6 that Vitale would take an…
Tag: Cancer
Monsanto Ordered to Pay Over $1.5 Billion in Roundup Verdict
[ad_1] Bayer AG’s Monsanto unit was ordered by a Missouri jury to pay more than $1.5 billion to three former users of its Roundup weedkiller who blamed their cancers on…
Pfizer and Astellas’ XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting
[ad_1] XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy* in nonmetastatic castration-sensitive prostate cancer TOKYO and NEW YORK,…
Are Generic Drugs Too Cheap for Their Own Good?
[ad_1] More than 90% of prescriptions in the US are filled with generic drugs. These cheaper alternatives to branded medications have expanded access to care for millions of Americans while…
First Patient Dosed in Phase III ProstACT GLOBAL Study of Antibody-based Prostate Cancer Therapy Candidate, TLX591
[ad_1] MELBOURNE, Australia, Nov. 12, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in the Company’s Phase III…
Several children with cancer and serious blood disorders evacuated from Gaza
[ad_1] More than a dozen children with cancer or other serious blood disorders have been safely evacuated from Gaza after weeks of difficult negotiations involving the U.S., Egypt, Israel and…
Mirati Therapeutics Receives Positive Opinion from CHMP for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation Following a Re-Examination Procedure
[ad_1] SAN DIEGO, Calif. and ZUG, Switzerland, Nov. 10, 2023 /PRNewswire/ — Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage biotechnology company, today announced that following a re-examination procedure, the…